Substance Use Archives - PsychPartners

Cognitive Impairment in Substance Use Disorders

Alcohol Cannabis Cognition Disorders Methamphetamine Opioids Research Research for the Public Stimulants Substance Use

Cognitive Impairment in Substance Use Disorders

October 2, 2026by Chris Aiken, MD0

How Addictive Is Methylphenidate?

ADHD Disorders Research Research for the Public Stimulants Substance Use

How Addictive Is Methylphenidate?

September 29, 2026by Chris Aiken, MD0

Zonisamide Lowers Drinking, Not Binges

Addiction Meds Alcohol Disorders Medications Research Substance Use

Zonisamide Lowers Drinking, Not Binges

September 24, 2026by Chris Aiken, MD0

Aripiprazole vs Paliperidone for Meth- and Cocaine-Psychosis

Cocaine Disorders Medications Methamphetamine Research Schizophrenia and Psychosis Stimulants Substance Use Top Research

Aripiprazole vs Paliperidone for Meth- and Cocaine-Psychosis

August 30, 2026by Chris Aiken, MD1

Naltrexone vs Buprenorphine for Opioid Use Disorder

Disorders Opioids Research Substance Use

Naltrexone vs Buprenorphine for Opioid Use Disorder

August 27, 2026by Chris Aiken, MD0

Naltrexone’s Safety in Cirrhosis

Alcohol Disorders Med-Psych Research Substance Use

Naltrexone’s Safety in Cirrhosis

August 23, 2026by Chris Aiken, MD0

Cannabis Use Disorder is Rising in Severity

Alcohol Cannabis Disorders Research Substance Use

Cannabis Use Disorder is Rising in Severity

August 22, 2026by Chris Aiken, MD0

Dronabinol: First Trial in PTSD Nightmares

Cannabis Disorders PTSD Research Sleep Top Research

Dronabinol: First Trial in PTSD Nightmares

August 21, 2026by Chris Aiken, MD0

How Much Alcohol is Safe?

Alcohol Disorders Research Research for the Public Substance Use

How Much Alcohol is Safe?

August 19, 2026by Chris Aiken, MD0

The FDA Erred with Oxycontin. Here’s the History they Ignored.

Disorders Opioids Research Research for the Public Substance Use

The FDA Erred with Oxycontin. Here’s the History they Ignored.

August 17, 2026by Chris Aiken, MD0

Dosing Buprenorphine in the Fentanyl Era

Addiction Meds Disorders Medications Opioids Research Substance Use

Dosing Buprenorphine in the Fentanyl Era

August 3, 2026by Chris Aiken, MD2

How Naltrexone-Bupropion Treats Meth Use Disorder

Addiction Meds Depression Disorders Methamphetamine Research Substance Use

How Naltrexone-Bupropion Treats Meth Use Disorder

July 29, 2026by Chris Aiken, MD0

Oral Ozempic Delivers Mixed Results on Alcohol Use

Alcohol GLP1 Agonists Medications Research Substance Use

Oral Ozempic Delivers Mixed Results on Alcohol Use

July 29, 2026by Chris Aiken, MD0

Ketamine for Addiction

Addiction Meds Alcohol Cocaine Disorders Ketamine Medications Opioids Research Substance Use

Ketamine for Addiction

July 24, 2026by Chris Aiken, MD0

How to Personalize Meds for Alcohol Use Disorder

Addiction Meds Alcohol Disorders Med-Psych Research Substance Use

How to Personalize Meds for Alcohol Use Disorder

July 23, 2026by Chris Aiken, MD0

Buprenorphine vs Naltrexone: A Large Study

Addiction Meds Medications Opioids Research Substance Use

Buprenorphine vs Naltrexone: A Large Study

July 15, 2026by Chris Aiken, MD0

New Guidelines For Substance Use Disorders

Addiction Meds Alcohol Cannabis Disorders Methamphetamine Opioids Research Sedatives Substance Use

New Guidelines For Substance Use Disorders

July 12, 2026by Chris Aiken, MD2

Six Years in Prison for Over-prescribing Adderall

ADHD Disorders Medications Methamphetamine Research Stimulants Substance Use

Six Years in Prison for Over-prescribing Adderall

July 10, 2026by Chris Aiken, MD0

Addiction Meds Disorders Med-Psych Opioids Research Substance Use

Matching Opioid MAT for Complex Patients

July 10, 2026by Chris Aiken, MD0

How Fast Does the Brain Recover from Cannabis?

Cannabis Cognition Disorders Research Research for the Public Substance Use

How Fast Does the Brain Recover from Cannabis?

July 9, 2026by Chris Aiken, MD0